Checkpoint Therapeutics, Inc. (CKPT)
NASDAQ: CKPT · Real-Time Price · USD
2.460
-0.060 (-2.38%)
Sep 18, 2024, 4:00 PM EDT - Market closed
Checkpoint Therapeutics Market Cap
Checkpoint Therapeutics has a market cap or net worth of $110.74 million as of September 18, 2024. Its market cap has increased by 151.12% in one year.
Market Cap
110.74M
Enterprise Value
105.79M
1-Year Change
151.12%
Ranking
Category
Stock Price
$2.46
Market Cap Chart
Since June 26, 2017, Checkpoint Therapeutics's market cap has decreased from $252.20M to $110.74M, a decrease of -56.09%. That is a compound annual growth rate of -10.76%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 17, 2024 | 113.40M | 110.39% |
Dec 29, 2023 | 53.90M | 13.47% |
Dec 30, 2022 | 47.50M | -81.77% |
Dec 31, 2021 | 260.50M | 44.80% |
Dec 31, 2020 | 179.90M | 173.82% |
Dec 31, 2019 | 65.70M | 5.97% |
Dec 31, 2018 | 62.00M | -37.37% |
Dec 29, 2017 | 99.00M | -60.75% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eledon Pharmaceuticals | 105.09M |
Leap Therapeutics | 104.84M |
Annovis Bio | 104.56M |
Monogram Technologies | 103.98M |
Seer, Inc. | 103.82M |
Werewolf Therapeutics | 102.26M |
Oramed Pharmaceuticals | 101.51M |
Metagenomi | 101.06M |